Michigan Medicine News Break

An early clinical trial at U-M finds that a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment. For more on this story, visit https://labblog.uofmhealth.org/lab-report/new-drug-shows-encouraging-survival-results-for-pancreatic-cancer See acast.com/privacy for privacy and opt-out information.